Pharmaceutical manufacturers historicially reaped the benefits of operating independently in pricing and discounting drugs based on volume sold in the United States.
Heather A. Brand, PharmD, MSPBA Candidate
Advertisement
Articles by Heather A. Brand, PharmD, MSPBA Candidate
The biggest spender doesn’t always come out ahead in the world of specialty medications.
Performance-based contracting is challenging the current paradigm in specialty pharmacy.
Advertisement
Latest Updated Articles
The Biggest Spender Doesn't Always Come Out Ahead: Value-Based Outcomes in the US Drug MarketPublished: October 24th 2016 | Updated:
The Demand for Outcomes in the US Drug MarketPublished: December 12th 2016 | Updated:
The Importance of Outcomes in High Cost Drug TherapiesPublished: December 29th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
4
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
5
